- Home
- PROK vs HRZN Comparison
PROK vs HRZN Comparison
Compare PROK & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PROK | HRZN |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 331.2M | 295.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | PROK | HRZN |
|---|---|---|
| Price | $2.15 | $4.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $7.40 | $6.80 |
| AVG Volume (30 Days) | 504.1K | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 32.20% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $76,000.00 | N/A |
| Revenue This Year | $1,010.19 | $19.99 |
| Revenue Next Year | N/A | $27.95 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $4.00 |
| 52 Week High | $7.13 | $9.52 |
Technical Indicators
Market Signals| Indicator | PROK | HRZN |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 18.30 |
| Support Level | $2.09 | $4.00 |
| Resistance Level | $2.58 | $6.81 |
| Average True Range (ATR) | 0.16 | 0.27 |
| MACD | -0.01 | -0.14 |
| Stochastic Oscillator | 2.20 | 1.89 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.